Show Summary Details
Page of

Antiepileptic Drugs in Patients With Liver Disease 

Antiepileptic Drugs in Patients With Liver Disease
Chapter:
Antiepileptic Drugs in Patients With Liver Disease
Author(s):

Ali A. Asadi-Pooya

and Michael R. Sperling

DOI:
10.1093/med/9780190214968.003.0013
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 19 August 2019

The use of antiepileptic drugs (AEDs) in the presence of liver diseases and hepatic dysfunction is associated with an increased risk of adverse effects. Knowledge of the mechanisms of metabolism and elimination of these drugs is crucial when selecting an AED in epilepsy patients with liver disease.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.